9 Alzheimers Disease Clinical Trials in Hialeah, FL (2026)

Q: How do I join a clinical trial in Hialeah?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Hialeah research site will contact you.

Recruiting Alzheimers Disease Studies in Hialeah

NCT06841679Recruiting

Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma

This is a multi-national, open-label, randomized, seamless phase II/III clinical study of UTD2 combined with fluoropyrimidine- and platinum-containing therapy to evaluate the efficacy and safety in pa...

Hialeah, FLPHASE2778 participantsBeijing Biostar Pharmaceuticals Co., Ltd.

View Study Details

NCT07431853Recruiting

A Study to Learn About mRNA Vaccines Against Influenza in Adults

The purpose of this study is to learn about safety in participants taking the study vaccine (mRNA-based vaccine) and the ability of the study vaccine to trigger the body's immune response, targeting t...

Hialeah, FLPHASE2770 participantsPfizer

View Study Details

NCT06651567Recruiting

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia

This is a multicenter, randomized, double-blind, placebo-controlled, flexible-dose study of the efficacy, safety, and tolerability of ITI-1284 in patients with agitation associated with Alzheimer's de...

Hialeah, FLPHASE2320 participantsIntra-Cellular Therapies, Inc.

View Study Details

NCT06833073Recruiting

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Researchers are looking for new ways to treat people with high-risk non-muscle invasive bladder cancer (HR NMIBC). NMIBC is cancer in the tissue that lines the inside of the bladder but has not spread...

Hialeah, FLPHASE2308 participantsMerck Sharp & Dohme LLC

View Study Details

NCT05641688Recruiting

[18F]PI-2620 Phase 3 Histopathological Study

This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with \[18F\]PI-2620 for detection of tau deposition in subjects with Al...

Hialeah, FLPHASE3200 participantsLife Molecular Imaging Ltd

View Study Details

NCT05685433Recruiting

A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

A prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects with urgency urinary incontinence (UUI)....

Hialeah, FLNA200 participantsValencia Technologies Corporation

View Study Details

NCT07262619Recruiting

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

The goal of this clinical trial is to determine the most effective dose of EIK1005 that a person can take safely. Additionally, this study will test how well EIK1005 is tolerated alone and in combinat...

Hialeah, FLPHASE1160 participantsEikon Therapeutics

View Study Details

NCT07633470Recruiting

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

The primary purpose of this study is to evaluate the safety and tolerability of Zunveyl® over 12 weeks of routine clinical use in adults with mild to moderate Alzheimer's disease....

Hialeah, FLPHASE4150 participantsAlpha Cognition, Inc

View Study Details

NCT07244263Recruiting

A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

Hidradenitis Suppurativa (HS) is a skin condition that causes deep, painful bumps on the skin. These bumps usually appear in an area where the skin rubs together. They start as small bumps but may bec...

Hialeah, FLPHASE290 participantsTakeda

View Study Details

About Alzheimers Disease Clinical Trials in Hialeah

Alzheimer's disease is a progressive brain disorder that destroys memory, thinking skills, and the ability to carry out daily tasks. It is the most common cause of dementia, affecting over 6.7 million Americans age 65 and older. The disease is characterized by amyloid-beta plaques and tau tangles in the brain. Recent FDA approvals of anti-amyloid antibodies like lecanemab (Leqembi) and donanemab have opened a new era of disease-modifying treatments. Clinical trials are now exploring next-generation amyloid-clearing therapies, tau-targeting treatments, anti-inflammatory approaches, and combination strategies. Early-stage patients with mild cognitive impairment or early Alzheimer's are frequently sought for enrollment, and many trials now use blood-based biomarkers for screening.

There are currently 9 alzheimers disease clinical trials recruiting participants in Hialeah, FL. These studies are seeking a combined 2,976 participants. Research is being sponsored by Beijing Biostar Pharmaceuticals Co., Ltd., Pfizer, Intra-Cellular Therapies, Inc. and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Alzheimers Disease Clinical Trials in Hialeah — FAQ

Are there alzheimers disease clinical trials in Hialeah?

Yes, there are 9 alzheimers disease clinical trials currently recruiting in Hialeah, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Hialeah?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hialeah research site will contact you about next steps.

Are clinical trials in Hialeah free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hialeah studies also compensate for your time and travel.

What alzheimers disease treatments are being tested?

The 9 active trials in Hialeah are testing new therapies including novel drugs, biologics, and treatment approaches for alzheimers disease.

Data updated October 12, 2026 from ClinicalTrials.gov